Medical Management of Diabetes and Heart DiseaseCRC Press, 6 mrt 2002 - 314 pagina's This state-of-the-art reference details current and effective symptom-specific strategies for the diagnosis and management of diabetic patients-emphasizing the exploration of therapeutic options available for the treatment of accelerated coronary complications associated with diabetes. |
Inhoudsopgave
| 1 | |
| 9 | |
Chapter 3 Recognition and Assessment of Insulin Resistance | 35 |
Chapter 4 Hypertension Diabetes and the Heart | 65 |
Chapter 5 Hyperlipidemia Diabetes and the Heart | 85 |
Therapeutic Implications for Patients with Type 2 Diabetes | 105 |
Syndrome X | 117 |
Chapter 8 Detection and Diagnosis of Syndromes of Insulin Resistance and of Diabetes Mellitus | 137 |
Implications for Heart Disease | 177 |
Chapter 12 Management of Patients with Diabetes and Coronary Artery Disease | 185 |
Chapter 13 Pathophysiology and Management of Congestive Heart Failure in Patients with Diabetes Mellitus | 211 |
Coronary Interventions and Coronary Surgery | 231 |
Chapter 15 Nonpharmacological Reduction of Cardiovascular Risk | 259 |
Elucidation of Mechanisms as Targets for Therapy | 273 |
About the Editors | 279 |
| 281 | |
Chapter 9 Polycystic Ovary Syndrome Insulin Resistance and Cardiovascular Disease | 149 |
Chapter 10 Detection and Diagnosis of Heart Disease in Diabetic and Prediabetic Subjects | 163 |
Back Cover | 293 |
Overige edities - Alles bekijken
Medical Management of Diabetes and Heart Disease Burton E. Sobel,David J. Schneider Geen voorbeeld beschikbaar - 2002 |
Veelvoorkomende woorden en zinsdelen
abnormalities activity acute addition agents angioplasty appears associated atherosclerosis benefit blood glucose blood pressure CABG cardiac Cardiol cause cells changes cholesterol Circulation clinical compared complications concentrations contribute coronary artery disease decreased demonstrated diabetes mellitus diabetic patients dysfunction dyslipidemia effects elevated evidence exercise factors function glucose HDL cholesterol heart disease higher hyperglycemia hyperinsulinemia hypertension impaired important improve increased individuals initial insulin receptor insulin resistance insulin sensitivity intensive less levels lipid lipoprotein long-term lower major mechanisms metabolic mg/dL mortality muscle myocardial infarction nondiabetic normal obesity observed patients with diabetes patients with type PCOS plasma platelet population potential prevention progression protein ramipril randomized rates recently receptor reduced reported response revascularization risk risk factors role shown significant specific stenting studies subjects suggest syndrome therapy tion tissue treated treatment trial triglycerides type 2 diabetes vascular weight women